Novo Nordisk A/S - share repurchase programme
January 08, 2024 06:11 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 08 January 2024 – On 6 November 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk enters into research collaborations with Omega Therapeutics and Cellarity on novel treatment approaches for cardiometabolic diseases
January 04, 2024 05:59 ET
|
Novo Nordisk A/S
Omega collaboration will leverage the company’s platform to develop an epigenomic controller as part of a new approach to obesity managementCellarity collaboration will build upon initial work and...
Novo Nordisk A/S - share repurchase programme
December 22, 2023 06:52 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 22 December 2023 – On 6 November 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk A/S - share repurchase programme
December 18, 2023 08:37 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 18 December 2023 – On 6 November 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk A/S - share repurchase programme
December 11, 2023 08:27 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 11 December 2023 – On 6 November 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk A/S - share repurchase programme
December 04, 2023 07:42 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 04 December 2023 – On 6 November 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk A/S - share repurchase programme
November 27, 2023 09:00 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 27 November 2023 – On 6 November 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk invests more than 16 billion Danish kroner in expansion of production facilities in Chartres, France
November 23, 2023 11:02 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 23 November 2023 – Novo Nordisk today announced the investment of more than 16 billion Danish kroner (2.1 billion euros) starting in 20231 to expand the existing production site in...
Novo Nordisk A/S - share repurchase programme
November 20, 2023 10:03 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 20 November 2023 – On 6 November 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
November 14, 2023 06:07 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 14 November 2023 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...